Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Proud Boys member arrested
Deadly blast at Pak rally
Reunite after 10-year feud
'Bed poverty' in UK
2 dead after plane crash
Calif. minimum wage raised
Teen struck by lightning, dies
'I feel pretty good'
'I'm incredibly sorry'
Another Taylor Swift surge?
New song collaboration
Tributes pour in for Gambon
Set for hip surgery
Musk livestreams border
Complete winners list
Human trafficking arrest
Bakhtiari on injured reserve
Get into heated exchange
Nia Long slams Celtics
Man wins $8.75M lottery
Expecting first baby
Debate draws 9.5M viewers
Orioles clinch AL East title
US economy grew by 2.1%
Biopic series in development
Gravy settles with Astley
Philippe, Rina could merge
Settles rape lawsuit
Tosses helmet into stands
Recalled over salmonella risk
Nike beats profit estimates
NM man shot at protest
No govt. shutdown for parks
Sued for racial harassment
No Fat Bear Week?
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
162,000 results
11h
First FDA Approved Drug to Slow Alzheimer’s
Joan was diagnosed with early-stage Alzheimer’s disease. There was nothing doctors could do. But now, a recently FDA-approved ...
19h
FDA advisers vote against experimental ALS treatment pushed by patients
The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm’s stem cell-based treatment has not ...
朝日新聞社10d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 JST Share Tweet list Print This image provided by Eisai in January 2023 shows vials and packaging for ...
8don MSN
Medical Moment: FDA approves first-ever drug to slow Alzheimer’s
There is no cure yet, but now, a newly FDA-approved drug is helping to slow its progression before it’s too late.
pharmaphorum4d
FDA issues draft guidance for Alzheimer’s drug development
The US FDA has issued proposal guidance to assist companies developing new treatments for patients in the early stages of Alzheimer’s disease, before the onset of noticeable (overt) dementia.
Sentinel Colorado
2d
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works
"FDA is the 800-pound gorilla here and if they're convinced that the drug doesn't work it's very hard to change their minds," ...
3d
After US approval, Japan approves Leqembi, its first Alzheimer's drug
Japan’s health ministry has approved Leqembi, a drug for Alzheimer’s decease that was jointly developed by Japanese and U.S. pharmaceutical companies.
Washington Examiner28d
FDA needs to let go of its risk-averse regulatory model
The FDA also gave full approval to a drug called Leqembi, which slowed Alzheimer’s patients’ functional and cognitive decline by 27% over 18 months, according to trial data.
The Financial Times25d
Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant
We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...
朝日新聞社1d
Alzheimer’s drug lecanemab set to soon be approved for use in Japan
A medication that could help treat early stages of Alzheimer's disease is on track to be approved for manufacturing and sales in Japan after being endorsed by a health ministry expert panel on ...
ABC 17 News
18h
Experts look for ways to help prevent and treat Alzheimer’s disease
Lecanemab, better known as Leqembi, is the first traditionally approved treatment to address the underlying biology of ...
WISH-TV
1d
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices